logo-loader
RNS
viewSativa Group PLC

Sativa Group PLC - Launch of cannabinoid CBG hand cleanser

RNS Number : 4972G
Sativa Group PLC
17 March 2020
 

Press Release

 

17 March 2020

 

 

 

 

Sativa Group Plc

 

("Sativa" or "the Company") 

 

Launch of cannabinoid cannabigerol (CBG) hand cleanser 

 

Sativa Group Plc [NEX: SATI], the UK's leading quoted CBD wellness and medicinal cannabis Group, has commenced production of a cannabigerol (CBG) and alcohol-based hand cleanser in response to the increased need for hand sanitation as a result of Covid-19.

 

Existing research and commercially available products show evidence that CBG is an effective antibacterial agent and is also believed to be effective in combatting MRSA, one of the most common hospital superbugs.  As the Company continues its research, other formats may become available as we work with our supply chain to source all necessary raw materials.  The hand cleanser is expected to be available for sale in approximately ten days, subject to the Company receiving packaging and labelling as planned. 

 

George Thomas, Managing Director of Sativa subsidiary Goodbody Botanicals, said: "CBG has already proven itself as impactful in terms of combatting germs and, when coupled with alcohol, makes it an ideal hand cleanser.  We are pleased to be able to supply what, we hope, will be a tool in combatting the spread of this virus."  

 

"The UK and the world is facing a health crisis and at Sativa, while we are continuing focus on making the highest quality products and building the UK's leading CBD Wellness brands, we have prioritized new product development to help people in this period", said Henry Lees-Buckley, CEO of the Sativa Group.  

 

 

-     Ends -

Media enquiries. 

Abchurch Communications

Julian Bosdet

+44 (0)207 4594 4070 

+44 (0) 7771 663 886 

[email protected]

www.abchurch-group.com

 

 

For further information please contact: 

 

Henry Lees-Buckley 

Chief Executive Officer

Sativa Group Plc 

+44 (0) 20 7971 1255

 

[email protected]

www.sativagroup.co.uk

 

Joseph Colliver

Chief Financial Officer

Sativa Group Plc 

+44 (0) 20 7971 1255

 

[email protected] 

www.sativagroup.co.uk

 

NEX Exchange Corporate Adviser

 

Corporate Finance 

Stephen Keys / Max Gould 

Cenkos Securities plc 

+44 (0) 20 7397 8900

 

 

Equity Sales 

Julian Morse

Cenkos Securities

+44 (0) 20 7397 8900

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRAMZGMFKNKGGZM

Quick facts: Sativa Group PLC

Price: -

Market: NEX
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Sativa Investments PLC acquires UK-based PhytoVista Laboratories

Geremy Thomas, chief executive of Sativa Investments PLC (NEX:SATI), tells Proactive's Andrew Scott they've agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000. The British medicinal cannabis investment vehicle will pay £235,000...

on 4/7/18